SSDRCT: The New Skin Stretching Device for Treatment of Limb Tension Wounds

Sponsor
The First Affiliated Hospital of Dalian Medical University (Other)
Overall Status
Unknown status
CT.gov ID
NCT03141502
Collaborator
(none)
100
1
2
17.7
5.7

Study Details

Study Description

Brief Summary

A randomized controlled trial is performed to evaluate the effectiveness and safety of the Skin Stretching Device (SSD) on limb tension incision closure by comparing whether the differences in wounds area, wounds closure time and scar assessment between the SSD and the skin grafting are statistically significant.

Condition or Disease Intervention/Treatment Phase
  • Device: Skin stretching device (SSD)
  • Procedure: Skin grafting
Phase 4

Detailed Description

Design:

This study is a multicenter and randomized control study with the participation of 15 major national or regional central hospitals. And the whole sample size is set to be 100 patients.

Patients who have been screened by inclusion and exclusion criteria will be randomly (non-transparent envelope) assigned to Skin Stretching Group (SS Group) or Skin Grafting Group (SG Group). Patients of both group will undergo surgical debridement for the same principle, while the Skin Stretching Device is used for the patients of SS Group for incision closure and the Skin Grafting is used for the patients of SG group for incision closure.

Outcome evaluation:

Wound and scar evaluation during surgery, three and six months after surgery will include the following parameters:

  • surface area;

  • Vancouver scar scale (VSS)

  • vascularization and pigmentation;

  • dermal architecture. After 3 and 6 months patients will undergo a biopsy of the scar under local anesthesia. The experimental group, treated with the SSD will undergo one extra biopsy of the formerly stretched skin.

Safety evaluation:

During the trial, adverse events are observed and evaluated. Adverse reactions to clinical manifestations are followed and recorded till the symptoms disappear. The subject with serious adverse events shall withdraw from the study and be treated accordingly.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
The New Skin Stretching Device for Treatment of Limb Tension Wounds: A Multicenter Randomized Controlled Clinical Study
Anticipated Study Start Date :
May 11, 2017
Anticipated Primary Completion Date :
Aug 31, 2018
Anticipated Study Completion Date :
Oct 31, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Skin Stretching Device (SSD)

the wound is primarily closed by aid of the SSD after necessary surgical debridement.

Device: Skin stretching device (SSD)
By making use of skin viscoelasticity, the special metal crochet of SSD would be embedded in both sides skin of the wound. Multiple cycles of stretching and relaxing wound lead to extended skin, changing the high tension incision into a low tension incision and facilitating the direct suture.

Active Comparator: Skin Grafting (SG)

the wound is primarily closed by the technique of skin grafting after necessary surgical debridement.

Procedure: Skin grafting
the standard technique of skin grafting after wound preparation.

Outcome Measures

Primary Outcome Measures

  1. the change of surface area of the scar [change from surgery at 6 months]

    it is performed by tracing the area of the scar directly onto non-stretchable transparent sterile sheets. then digitized and analyzed by software.

Secondary Outcome Measures

  1. Operation time [during surgery]

    refers to the time required for the application of skin stretching device or skin grafting

  2. Wound site and wound healing time [from surgery to 6 months]

    record the site of the operation, and the time from the beginning of surgery to the complete healing of the wound.

  3. Vancouver scar scale (VSS) [3 and 6 months after surgery]

    evaluate the scar scale by VSS

  4. scar vascularization index [3 and 6 months after surgery]

    use photometric analyzer to measure its erythema index, assessing its angiogenesis and vascularization

  5. scar pigmentation index [3 and 6 months after surgery]

    use photometric analyzer to measure its melanin index, assessing its pigmentation

  6. collagen fibers arrangement under electron microscopy [surgery and 6 months after surgery]

    use the drilling device to take the skin tissue of the diameter of 3mm for histological examination, measuring the collagen fibers arrangement by Electron microscopy

  7. dermal matrix arrangement under electron microscopy [surgery and 6 months after surgery]

    use the drilling device to take the skin tissue of the diameter of 3mm for histological examination, measuring the dermal matrix arrangement by Electron microscopy

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion criteria:
  1. Ageā‰„18 years old

  2. Tension incision that cannot be directly closed due to limb trauma or surgical debridement

  3. Incision that cannot be directly closed after the incision decompression for fascia compartment syndrome and ischemia and reperfusion injury

  4. Both sides of the incision skin suitable for skin stretching

Exclusion criteria:
  1. Age <18 years old

  2. Skin disease

  3. Keloid history

  4. Local or systemic use of hormones

  5. Systemic diseases: for example, diabetes, immunodeficiency disease, vascular disease and etc.

  6. Other poor general state to result in inability for trial;

  7. Mental illness.

Contacts and Locations

Locations

Site City State Country Postal Code
1 the First Affiliated Hospital of Dalian Medical University Dalian Liaoning China 116011

Sponsors and Collaborators

  • The First Affiliated Hospital of Dalian Medical University

Investigators

  • Principal Investigator: Xin Tang, The First Affiliated Hospital of Dalian Medical University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
The First Affiliated Hospital of Dalian Medical University
ClinicalTrials.gov Identifier:
NCT03141502
Other Study ID Numbers:
  • LCSY2017-05
First Posted:
May 5, 2017
Last Update Posted:
May 5, 2017
Last Verified:
Apr 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by The First Affiliated Hospital of Dalian Medical University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 5, 2017